Sepsis Clinical Trials

Find Sepsis Clinical Trials Near You

Dysautonomia in Children With Type 1 Diabetes: DysDiab Single-center Study

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Some physiological factors, such as physical activity, or pathological factors, such as sepsis or diabetes, are known to modulate the overall autonomic activity and the individual's intrinsic capacity to regulate their sympathetic and parasympathetic balance. These conditions can alter the physiological autonomic balance, sometimes with positive consequences on the FC-breathing control and blood pressure adjustment, depending on the individual's position and the status of blood volume, but sometimes with deleterious effects, such as poor regulation of sinus cardiac activity and respiration rate. Cardiovascular autonomic neuropathy is a major complication of type 1 diabetes. Several studies have described autonomic dysfunction in patients with type 1 diabetes, but these data are derived from cohorts of adults and adolescents or short ECG recordings at rest. Moreover, there are often confounding factors such as sedentary/physical activity, overweight, exposure to post-pubertal hormonal peaks, toxic drugs, or cardiac therapy. These factors don't greatly influence children's autonomic physiological maturation, whereas diabetes can sometimes exist for several years. In this population, the search for cardiac dysautonomia is entirely appropriate.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Maximum Age: 17
Healthy Volunteers: t
View:

• Parents affiliates or entitled to the French Social Security Fund

• Children\<18 years with type 1 diabetes followed in consultation at the University Hospital of Saint-Etienne

• Children under 18 years of age, matched for age (±6 months) and sex, without diabetes or dysautonomia (control group), who have not undergone anesthesia within the 2 months preceding the recording and are not receiving any cardiac (beta-blocker) or antiarrhythmic treatment.

Locations
Other Locations
France
Chu de Saint-Etienne
RECRUITING
Saint-etienne
Contact Information
Primary
Hugues PATURAL, MD PhD
hugues.patural@chu-st-etienne.fr
(0)4 77 82 82 42
Backup
Meryem BRITAL, CDP
meryem.brital@chu-st-etienne.fr
(0)4 77 42 06 83
Time Frame
Start Date: 2025-12-22
Estimated Completion Date: 2027-05
Participants
Target number of participants: 100
Treatments
Experimental: Diabetic subjects
50 pediatric diabetic subjects with at least 5 years of type 1 diabetes).
Active_comparator: healthy group
50 healthy subjects matched for age and sex
Sponsors
Leads: Centre Hospitalier Universitaire de Saint Etienne

This content was sourced from clinicaltrials.gov